Design Therapeutics Inc.

NASDAQ: DSGN · Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Design Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.59M -66.86M -63.31M -35.53M
Depreciation & Amortization
-5.6M 537K 406K 129K
Stock-Based Compensation
13.07M 13.09M 10.93M 4.69M
Other Working Capital
226K 1.97M -3.39M -1.02M
Other Non-Cash Items
6K -6.05M -1.33M 19K
Deferred Income Tax
n/a n/a n/a -77K
Change in Working Capital
-993K 728K 1.99M 1.4M
Operating Cash Flow
-43.1M -58.56M -51.32M -29.38M
Capital Expenditures
-340K -256K -918K -1.54M
Cash Acquisitions
n/a n/a 39K 52.11K
Purchase of Investments
-230.18M -224.7M -313M -86.26M
Sales Maturities Of Investments
274.47M 277.5M 92.89M 34.16M
Other Investing Acitivies
n/a n/a n/a -52.11K
Investing Cash Flow
43.95M 52.54M -220.99M -53.64M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -427K 228K
Financial Cash Flow
513K 724K 235K 379.21M
Net Cash Flow
1.36M -5.3M -272.07M 296.19M
Free Cash Flow
-43.45M -58.82M -52.23M -30.91M